MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
about
MicroRNA-mediated autophagic signaling networks and cancer chemoresistanceMiRNAs and miRNA Polymorphisms Modify Drug ResponseGrape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cellsMiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 CellsmicroRNA 490-3P enhances the drug-resistance of human ovarian cancer cellsmiR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cellsMicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells.Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencingVerbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancerHuman hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCCMiR-27 as a prognostic marker for breast cancer progression and patient survival.An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells.Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells.Clinically relevant microRNAs in ovarian cancermiR-27a promotes cell proliferation and metastasis in renal cell carcinomaOvarian stem cells: From basic to clinical applications.miR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cellsClinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1Early detection biomarkers for ovarian cancer.MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyPrognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.Expression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell lines.Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.MicroRNAs as therapeutic targets in chemoresistance.Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancerRegulation of multidrug resistance by microRNAs in anti-cancer therapyAndrogen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line.Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?Epigenetic regulation of drug processing genes.Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants.microRNA regulation of cell viability and drug sensitivity in lung cancer.miRNAs as mediators of drug resistance.Epigenetic-dependent regulation of drug transport and metabolism: an update.
P2860
Q26859148-F825C5F1-7554-4B39-8B3C-C7253EEB668CQ28079075-D85C361E-CE3C-47D5-9BFF-0C52B9B20BDDQ28535383-D9D69AFB-E1FC-42B0-A9C5-01568E76452EQ28547840-1A2841E9-FED3-4E22-921E-0C9AC362C7B7Q34150950-BE4D67F6-7700-4888-A4C2-FECE6BA54E8AQ34151444-E6FE0F51-FD6E-4281-A5C5-CE069477FC7CQ34154782-5894507C-D3AF-4733-B1A7-CA74D250E970Q34276657-49A80133-2DEF-4145-9D36-B9030A42D483Q34321089-8A8B6C6D-07C1-4429-9AFF-BD2571CA1266Q34340501-9C38D3D2-9ABF-400C-93A1-A2DF81066F8FQ34508057-2A42DA1D-2477-4D29-9C47-0A7D0E5BF0E5Q34512567-09902854-5B5F-475E-BB9A-817F1A114BC2Q34523785-3BCE8F26-6413-40CA-8A2A-0441D7417AF9Q35061283-35ED6D36-01E4-4510-931D-513EC1E0B8B3Q35204609-34D41C3D-F6C1-42EE-8032-10C5EB0655CEQ35405970-31534196-4F53-4588-8EA0-B3B67B410F55Q35649789-22872512-2F0A-4A00-9ED4-358ACEF84965Q35785983-BE1FE693-832F-4D3E-8C86-6A557D4F96FFQ35837949-5A79C311-343E-4487-AE06-9B229247B0C0Q36079367-3FC21564-565F-4CE7-A05E-86AC3EBA075DQ36265840-07C2E84C-340E-46C0-A0BE-CF6A0B9BB652Q36320168-74414715-608F-42FA-8F73-43A13CCC9DE4Q36341067-298DD110-60ED-41CD-920C-519CFE0A86D8Q36520143-AEBDBEEF-6705-45AE-A73F-7E456874733CQ36537367-45A494C6-FF11-43DF-931D-7198F7E5AF22Q36618667-96F964D2-B9DE-454D-8FFE-2F1553F6CF3EQ36642134-CA63783A-8AA1-4E89-B65C-CDB1DF9A3AC1Q37013255-D17F2ACB-B104-4438-AFB3-D85763024433Q37206260-E70353BD-F8BD-4692-B392-4117B39C6CA8Q37335617-8B9C7D92-078E-458F-9C4E-58519279AA93Q37381107-14623B8F-8F3B-464D-82D2-A93250D1AFA9Q37386222-C25738F5-E539-43CD-B280-2E34BAB03033Q37587311-BBB7DE6A-D72A-431A-A0B7-1180DA521575Q37606208-65621CC5-E1C8-47CD-8BD6-C439427D944AQ37702543-E4C663C3-F2A1-4361-A74C-C336828F8BD9Q37865530-E1DE285E-4F23-4623-B8A0-69FE4A01D17EQ37995667-C5F94FA8-854A-442E-9C07-1EDE665D40CAQ38021509-83459C10-A50F-48A5-8B70-A44663BA1029Q38037620-898E3000-1ACB-4E97-9163-32B077EC7794Q38042440-ADCB2DB3-73B7-4FF7-9D75-7142116EDF0B
P2860
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@en
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@nl
type
label
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@en
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@nl
prefLabel
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@en
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@nl
P2093
P1433
P1476
MiR-27a modulates MDR1/P-glyco ...... in human ovarian cancer cells.
@en
P2093
Zehua Wang
P304
P356
10.1016/J.YGYNO.2010.06.004
P407
P577
2010-07-10T00:00:00Z